International Forum on Organoid Research and Developmental Biology
IFORDB
Official Invitation Letter Available
An official invitation letter will be provided upon successful registration for your participation in the conference.
Benefits of Registering as Listener
Access to All Conference Sessions
Plenary, keynote and parallel sessions
Networking Opportunities
Connect with global educators & researchers
Certificate of Participation
Digital certificate of participation
Invitation Letter Support
Official invitation letter after successful registration
Conference Kit / Digital Materials
E-proceedings & resource materials
Access to Keynote Sessions
Learn from leading experts & scholars
Conference Session Tracks
Aligned with UN Sustainable Development Goals
The conference's session tracks effectively support the following SDGs.
This track will explore the latest innovations in organoid technology, focusing on the development of novel methodologies for organoid generation and maintenance. Participants will discuss the implications of these advancements for enhancing the fidelity and functionality of organoid models.
SDG 3
SDG 4
This session will highlight the application of organoids in modeling various diseases, including cancer, neurodegenerative disorders, and genetic conditions. Researchers will present case studies demonstrating how organoid systems can recapitulate disease pathology and inform therapeutic strategies.
SDG 3
SDG 9
Focusing on the intersection of stem cell biology and organoid research, this track will cover the mechanisms underlying stem cell differentiation into organoids. Discussions will include the role of niche factors and signaling pathways in guiding organoid formation.
SDG 3
SDG 4
This session will delve into the potential of organoids in regenerative medicine, examining their use in tissue repair and transplantation. Presentations will address the challenges and successes in translating organoid technology into clinical applications.
SDG 3
SDG 9
This track will focus on the role of organoids in advancing precision medicine, particularly in personalized treatment strategies. Researchers will discuss how patient-derived organoids can be utilized for drug screening and therapeutic decision-making.
SDG 3
SDG 9
This session will explore the integration of organoids with tissue engineering approaches to create functional tissue constructs. Topics will include scaffold design, bioprinting techniques, and the challenges of vascularization in engineered organoids.
SDG 3
SDG 9
This track will address the ethical implications of organoid research, including issues related to consent, ownership, and the potential for organoid-derived entities. Participants will engage in discussions on establishing ethical guidelines for future research.
SDG 16
This session will highlight the translation of organoid research into clinical practice, focusing on diagnostic and therapeutic applications. Case studies will illustrate how organoids are being utilized in patient care and clinical trials.
SDG 3
SDG 9
This track will investigate the use of organoids to study immune responses in various contexts, including infection and autoimmune diseases. Researchers will present findings on how organoids can model interactions between immune cells and tissues.
SDG 3
SDG 16
This session will focus on the utility of organoid models in drug discovery and development, emphasizing their advantages over traditional cell culture systems. Presentations will cover high-throughput screening methods and the predictive power of organoids in pharmacology.
SDG 3
SDG 9
This track will provide a forward-looking perspective on the future of organoid research, discussing emerging trends and technologies. Participants will explore potential breakthroughs that could shape the next generation of organoid applications in health and medicine.
SDG 3
SDG 9